ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82 | -96.7% | 620 | -87.3% | 0.00% | – |
| Q2 2023 | $2,499 | -19.1% | 4,901 | 0.0% | 0.00% | – |
| Q1 2023 | $3,088 | -52.4% | 4,901 | -51.0% | 0.00% | -100.0% |
| Q4 2022 | $6,493 | -72.9% | 10,003 | -28.5% | 0.00% | 0.0% |
| Q3 2022 | $24,000 | +41.2% | 13,987 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | +88.9% | 13,987 | -7.3% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 15,087 | +183.3% | 0.00% | -100.0% |
| Q3 2021 | $10,000 | -28.6% | 5,326 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | -26.3% | 5,326 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $19,000 | 0.0% | 5,326 | -27.5% | 0.00% | 0.0% |
| Q3 2020 | $19,000 | +1800.0% | 7,348 | +1081.4% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 622 | +12.7% | 0.00% | – |
| Q3 2018 | $2,000 | -86.7% | 552 | -76.2% | 0.00% | -100.0% |
| Q1 2017 | $15,000 | -6.2% | 2,315 | -21.9% | 0.00% | -50.0% |
| Q4 2016 | $16,000 | – | 2,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |